Skip to main content
. 2016 Jul 18;95(28):e3344. doi: 10.1097/MD.0000000000003344

Figure 10.

Figure 10

Pos-trituximab imaging revealing an unchanged soft tissue mass on CT (A) but substantially reduced FDG avidity on PET (Comparison Figure 9 A and B).